Soluble forms of polyQ-expanded huntingtin rather than large aggregates cause endoplasmic reticulum stress
- PMID: 24217578
- DOI: 10.1038/ncomms3753
Soluble forms of polyQ-expanded huntingtin rather than large aggregates cause endoplasmic reticulum stress
Abstract
In Huntington's disease, as in other neurodegenerative diseases, it was initially thought that insoluble protein aggregates are the toxic species. However, growing evidence implicates soluble oligomeric polyglutamine-expanded huntingtin in cytotoxicity. Here we show that pathogenic huntingtin inhibits endoplasmic reticulum (ER)-associated degradation and induces ER stress before its aggregation into visible inclusions. All three branches of the unfolded protein response are activated. ER stress can be compensated by overexpression of p97/VCP, suggesting its sequestration by pathogenic huntingtin as a main cause. Stress correlates with the presence of huntingtin oligomers and is independent of continual huntingtin synthesis. Stress levels, measured in striatal neurons, are stabilized but only slowly subside on huntingtin aggregation into inclusions. Our results can be explained by the constant conversion of huntingtin monomers to toxic oligomers; large aggregates sequester the former, precluding further conversion, whereas pre-existing toxic oligomers are only gradually depleted.
Similar articles
-
Inhibition of endoplasmic reticulum stress counteracts neuronal cell death and protein aggregation caused by N-terminal mutant huntingtin proteins.Exp Cell Res. 2008 Mar 10;314(5):950-60. doi: 10.1016/j.yexcr.2007.12.025. Epub 2008 Jan 14. Exp Cell Res. 2008. PMID: 18255062
-
IRE1 plays an essential role in ER stress-mediated aggregation of mutant huntingtin via the inhibition of autophagy flux.Hum Mol Genet. 2012 Jan 1;21(1):101-14. doi: 10.1093/hmg/ddr445. Epub 2011 Sep 27. Hum Mol Genet. 2012. PMID: 21954231
-
Purification of neuronal inclusions of patients with Huntington's disease reveals a broad range of N-terminal fragments of expanded huntingtin and insoluble polymers.J Neurochem. 2005 Oct;95(1):125-36. doi: 10.1111/j.1471-4159.2005.03348.x. J Neurochem. 2005. PMID: 16181417
-
Converging pathways in the occurrence of endoplasmic reticulum (ER) stress in Huntington's disease.Curr Mol Med. 2011 Feb;11(1):1-12. doi: 10.2174/156652411794474419. Curr Mol Med. 2011. PMID: 21189122 Review.
-
The emerging role of the first 17 amino acids of huntingtin in Huntington's disease.Biomol Concepts. 2015 Mar;6(1):33-46. doi: 10.1515/bmc-2015-0001. Biomol Concepts. 2015. PMID: 25741791 Free PMC article. Review.
Cited by
-
Beneficial behavioral effects of chronic cerebral dopamine neurotrophic factor (CDNF) infusion in the N171-82Q transgenic model of Huntington's disease.Sci Rep. 2023 Feb 20;13(1):2953. doi: 10.1038/s41598-023-28798-4. Sci Rep. 2023. PMID: 36807563 Free PMC article.
-
1-Mesityl-3-(3-Sulfonatopropyl) Imidazolium Protects Against Oxidative Stress and Delays Proteotoxicity in C. elegans.Front Pharmacol. 2022 May 24;13:908696. doi: 10.3389/fphar.2022.908696. eCollection 2022. Front Pharmacol. 2022. PMID: 35685626 Free PMC article.
-
Connection Lost, MAM: Errors in ER-Mitochondria Connections in Neurodegenerative Diseases.Brain Sci. 2021 Oct 28;11(11):1437. doi: 10.3390/brainsci11111437. Brain Sci. 2021. PMID: 34827436 Free PMC article. Review.
-
When nature's robots go rogue: exploring protein homeostasis dysfunction and the implications for understanding human aging disease pathologies.Expert Rev Proteomics. 2018 Apr;15(4):293-309. doi: 10.1080/14789450.2018.1453362. Epub 2018 Mar 21. Expert Rev Proteomics. 2018. PMID: 29540077 Free PMC article. Review.
-
Neuroprotective Effect of IND1316, an Indole-Based AMPK Activator, in Animal Models of Huntington Disease.ACS Chem Neurosci. 2022 Jan 19;13(2):275-287. doi: 10.1021/acschemneuro.1c00758. Epub 2021 Dec 28. ACS Chem Neurosci. 2022. PMID: 34962383 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
